Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9727f1d4e6a16ee58430f2bb18e60b3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
filingDate |
2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0648097713161e402c1dd087718191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_addd80f3cf2750b169769646fcb3ddbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e571242fe7878179d2f1e7a19ae7467 |
publicationDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2573700-T3 |
titleOfInvention |
Peptide combinations for cat allergy vaccines |
abstract |
A pharmaceutical composition for use in a method of prevention or treatment of cat allergy in an individual, a composition comprising: (a) as the only therapeutic components: - the polypeptide consisting of the sequence APCVKRDVDLFLT (SEQ ID NO: 1) ; - the polypeptide consisting of the sequence EQVAQYKALPVVLENA (SEQ ID NO: 2); - the polypeptide consisting of the sequence KALPVVLENARILKNCV (SEQ ID NO: 3); - the polypeptide consisting of the sequence RILKNCVDAKMTEEDKE (SEQ ID NO: 4); - the polypeptide consisting of the sequence KENALSLLDKIYTSPL (SEQ ID NO: 5); - the polypeptide consisting of the sequence TAMKKIQDCYVENGLI (SEQ ID NO: 6); and - the polypeptide consisting of the sequence SRVLDGLVMTTISSSK (SEQ ID NO: 7); and (b) a pharmaceutically acceptable carrier or diluent. |
priorityDate |
2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |